FDA approves generic version of Jazz Pharma's sleep disorder drug
(Reuters) - The U.S. Food and Drug Administration said it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with narcolepsy, a kind of sleeping disorder.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Food and Drug Administration (FDA) | Health | Narcolepsy | Pharmaceuticals | Sleep Disorders | Sleep Medicine